Charlotte Robinson

DocwireNews

Although pediatric acute kidney injury (AKI) is associated with considerable morbidity and mortality, a precise definition, particularly regarding urine output (UO) thresholds, remains elusive. Adriana Torres de Melo Bezerra Gir&atilde;o and colleagues wanted to understand the optimal thresholds for defining and staging AKI in neonates and children aged 1 to 24 months and compare them with currently used Kidney Disease: Improving Global Outcomes (KDIGO) criteria.&nbsp;&nbsp;They conducted a prospective cohort study from 2018 to 2023 of patients who had cardiac surgery at a reference center in Brazil, had indwelling urinary catheters up to 48 hours after surgery, and had at least two serum creatinine measurements, including one before surgery. The primary study outcome was a composite of severe AKI (stage 3 AKI diagnosed solely by serum creatinine criterion), kidney replacement therapy, or hospital mortality.&nbsp;Of the 1,024 patients included in the study, 772 were younger children (aged 1 to 24 months) and 253 were neonates. The lowest UO at 24 hours as a continuous variable demonstrated good discriminatory capacity for the composite outcome in both groups (area under the curve&ndash;receiver operating characteristic [AUC-ROC], 0.75; 95% CI, 0.70-0.81 for neonates and AUC-ROC, 0.74; 95% CI, 0.68-0.79 for younger children). In the neonate group, the optimal thresholds were 3.0, 2.0, and 1.0 mL/kg per hour. In the group of younger children, the best thresholds were 1.8, 1.0, and 0.5 mL/kg per hour.&nbsp;&nbsp;Those optimal thresholds were then used for modified AKI staging for each age group. In the group of younger children, the modified criteria had discriminatory capacity comparable to that of the adult KDIGO criteria; the net improvement with the reclassification was near zero.&nbsp;&nbsp;However, in the neonate group, the modified criterion was associated with discriminatory capacity superior to that of the current KDIGO criteria (AUC-ROC, 0.74; 95% CI, 0.67-0.80 vs AUC-ROC, 0.68; 95% CI, 0.61-0.75;&#8239;P&lt;.05). The modified criterion was also associated with a net improvement compared with the neonatal KDIGO criteria (AUC-ROC, 0.74; 95% CI, 0.67-0.80 vs AUC-ROC, 0.68; 95% CI, 0.61-0.75;&#8239;P&lt;.05).&nbsp;&nbsp;In summary, the study results suggest that KDIGO criteria for the definition and staging of AKI in neonates may need adjustment.&nbsp;Source: <a href="https://doi.org/10.2215/CJN.0000000000000534" target="_blank" rel="noopener">Clinical Journal of the American Society of Nephrology</a>

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Urine Output Thresholds for Defining and Staging Pediatric AKI

Acute Kidney Injury

A study examined the optimal thresholds for defining and staging acute kidney injury (AKI) in neonates and young children compared with KDIGO criteria.

Urine Output Thresholds for Defining and Staging Pediatric AKI  

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe